Jisu Hong
M.S./PH.D. INTEGRATED COURSE from Sep 2021
Department of Biomedical Sciences, SNUCM
B.S. Department of chemistry, Chungnam National University,
Republic of Korea
Seoul National University Graduate School of Medicine, 26th undergraduate researcher
Research interests
Development of therapeutic antibodies, Therapeutic antibody engineering, CAR cell therapy
Awards
Selected as an Excellent Graduate Student in March 2022 under the 4th stage of the BK21 program
E-mail: redj0106@snu.ac.kr
Google scholar link: https://scholar.google.com/citations?user=DkqVHC0AAAAJ&hl =ko
Patent
5. CD222 특이적 항체, 상기 항체와 나노입자의 접합체 및 이를 이용한 유전자 전달 방법
(이창한，임진웅，홍지수，김병수，강형진)
10-2025-0137979
4. 항-EGFRvIII 항체 및 이를 포함하는 조성물
(이창한, 주민영, 진유진, 홍지수, 강형진)
10-2025-0137254
3. 메소텔린 표적의 신규 CAR 및 이를 발현하는 면역세포의 용도
(장미희, 이창한, 정주윤, 홍지수)
10-2025-0013774
2. 항-메소텔린 항체 및 이의 용도
(이창한, 홍지수)
10-2024-0059322
1. 엔도글린 항체 및 이의 다양한 적용 용도
(장미희, 윤종현, 신승훈, 이창한, 홍지수)
10-2023-0064543
Publication
4. Novel FRET-Based Immunological Synapse Biosensor for Prediction of CAR-T cell Function
Small Methods (IF: 10.7), Sep 2024
(Hae Nim Lee, Soojin Lee, Jisu Hong, Hyejin Yoo, Jiyun Jeong, Yong-Woo Kim, Hyun Mu Shin, Mihue Jang*,
Chang-Han Lee*, Hang-Rae Kim* and Jihye Seong*)
# Co-first author, *Co-corresponding author
3. Broad humoral and cellular immunity elicited by one dose mRNA vaccination 18 months after SARS-CoV-
2 infection
BMC Medicine (IF: 11.150), 20, 181 (2022)
(Chang Kyung Kang#, Hyun Mu Shin#, Pyoeng Gyun Choe, Jiyoung Park, Jisu Hong, Jung Seon Seo, Yung Hie
Lee, Euijin Chang, Nam Joong Kim, Minji Kim, Yong-Woo Kim, Hang-Rae Kim, Chang-Han Lee*, Jun-Young
Seo*, Wan Beom Park*, Myoung-don Oh
# Co-first author, *Co-corresponding author
2. Persistent Antibody Responses up to 18 Months after Mild SARS-CoV-2 Infection
Journal of Infectious Diseases (IF: 7.759), 17 March 2022
(Pyoeng Gyun Choe#, Jisu Hong#, Jiyoung Park, Euijin Chang, Chang Kyung Kang, Nam Joong Kim, Chang-
Han Lee*, Wan Beom Park*, and Myoung-don Oh)
# Co-first author, *Co-corresponding author
1. Distinctive immune response after one-year post COVID-19 according to the severity
Frontiers in Immunology (IF:8.786), 21 March 2022, vol 13, 830433
(Chang Kyung Kang#, Minji Kim#, Jisu Hong#, Gwanghun Kim, Soojin Lee, Pyoeng Gyun Choe, Nam Joong
Kim, Ik Soo Kim, Jun-Young Seo, Daesub Song, Dong-Sup Lee, Hyun Mu Shin, Chang-Han Lee*, Wan Beom
Park*, Hang-Rae Kim* and Myoung-don Oh)
# Co-first author, *Co-corresponding author
Hayoung Kwon and Chang-Han Lee *
*Co-corresponding author